Equity Details
Price & Market Data
Price: $0.297
Daily Change: -$0.0065 / 2.19%
Daily Range: $0.293 - $0.308
Market Cap: $29,293,040
Daily Volume: 379,007
Performance Metrics
1 Week: -7.98%
1 Month: -0.17%
3 Months: 12.74%
6 Months: -19.41%
1 Year: -2.47%
YTD: 5.37%
About IGC Pharma, Inc. (IGC)
Discover the investment profile of IGC Pharma, Inc. (IGC). With a price of 0.297, and a daily change of -$0.0065 / 2.19%. Market cap: 29,293,040. Performance figures include YTD and 52-week returns.
Company Details
Employees: 70
Sector: Health technology
Industry: Biotechnology
Country: United States
Details
IGC Pharma, Inc., a clinical stage pharmaceutical company, develops novel therapeutic candidates for neuropsychiatric and neurodegenerative disorders, with a primary focus on Alzheimer's disease in the United States and Colombia. The company's lead product is IGC-AD1 that is in Phase II clinical trial for the treatment of agitation in dementia due to Alzheimer's. Its pre-clinical stage product candidate includes TGR-63 and IGC-M3 to treat Alzheimer's disease. In addition, the company develops MINT-AD, an AI-driven assistant for healthcare providers. The company was formerly known as India Globalization Capital, Inc. and changed its name to IGC Pharma, Inc. in March 2023. IGC Pharma, Inc. was incorporated in 2005 and is headquartered in Potomac, Maryland.